The role of Gliadel wafers in the treatment of high-grade gliomas (Q38162925)

30 August 2017

0 references

The role of Gliadel wafers in the treatment of high-grade gliomas (English)

1 reference

30 August 2017

7

Ricardo J Komotar

1 reference

30 August 2017

Amade Bregy

1

1 reference

30 August 2017

Ashish H Shah

2

1 reference

30 August 2017

Maria V Diaz

3

1 reference

30 August 2017

Hayley E Pierce

4

1 reference

30 August 2017

Philip L Ames

5

1 reference

30 August 2017

Daniel Diaz

6

1 reference

30 August 2017

1 December 2013

1 reference

Expert Review of Anticancer Therapy

30 August 2017

1 reference

30 August 2017

13

1 reference

30 August 2017

12

1 reference

30 August 2017

1453-1461

1 reference

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy

30 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

A comprehensive outlook on intracerebral therapy of malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Gene expression profile of glioblastoma peritumoral tissue: an ex vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Monitoring the effects of BCNU chemotherapy Wafers (Gliadel) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Incorporating BCNU wafers into malignant glioma treatment: European case studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Brain tumor and Gliadel wafer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Risk factors for postcraniotomy surgical site infection after 1,3-bis (2-chloroethyl)-1-nitrosourea (Gliadel) wafer placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Fatal outcome related to carmustine implants in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: efficacy and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

The role of interstitial BCNU chemotherapy in the treatment of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radio

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: prospective, observational, multicenter study on 92 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Cerebral edema associated with Gliadel wafers: two case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2013.840090

10.1586/14737140.2013.840090

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference